Personal profile
Public Profile
Dr Thomas Pulliam has joined Lisa Butler’s lab as a postdoctoral researcher. He earned his PhD in Cell and Molecular Biology from the University of Houston in 2021. Most recently, he was a postdoctoral fellow in Daniel Frigo’s lab at MD Anderson Cancer Center, where he investigated the impact of metabolic syndrome on prostate cancer progression. In the Butler lab, Thomas is focused on leveraging spatial lipidomics to predict prostate cancer treatment responses and develop novel therapies. He is also interested in evaluating the efficacy of emerging treatments using patient-derived explants.
Education/Academic qualification
PhD, Cell and Molecular Biology, University of Houston
Award Date: 3 May 2021
Bachelor's Degree, Biology, Lamar University
Award Date: 15 Apr 2014
External positions
Postdoctoral Fellow, MD Anderson Cancer Centre
4 Mar 2021 → 16 Feb 2026
Keywords
- cancer biology
- prostate cancer
- Lipid Metabolism
- novel therapeutics
- dietary fatty acids
- nutrition
- translational medicine
- treatment prediction
- spatial omics
Collaborations and top research areas from the last five years
-
Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer
Lin, C., Pulliam, T. L., Han, J. J., Xu, J., Recio, C. V., Wilkenfeld, S. R., Shi, Y., Kushwaha, M., Bench, S., Ruiz, E., Senthilkumar, S., Dileep, J., Shepherd, P. D. A., Navone, N. M., Klekers, A. R., Whitley, E. M., Ittmann, M. M., Eberlin, L. S., Wang, W. & Frigo, D. E., 24 Jun 2025, In: Cell Reports. 44, 6, 115792.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Citations (Scopus) -
SGC-CAMKK2-1: A Chemical Probe for CAMKK2
Wells, C., Liang, Y., Pulliam, T. L., Lin, C., Awad, D., Eduful, B., O’Byrne, S., Hossain, M. A., Catta-Preta, C. M. C., Ramos, P. Z., Gileadi, O., Gileadi, C., Couñago, R. M., Stork, B., Langendorf, C. G., Nay, K., Oakhill, J. S., Mukherjee, D., Racioppi, L. & Means, A. R. & 5 others, , Jan 2023, In: Cells. 12, 2, 287.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Citations (Scopus) -
Regulation and role of CAMKK2 in prostate cancer
Pulliam, T. L., Goli, P., Awad, D., Lin, C., Wilkenfeld, S. R. & Frigo, D. E., Jun 2022, In: Nature Reviews Urology. 19, 6, p. 367-380 14 p.Research output: Contribution to journal › Article › peer-review
31 Link opens in a new tab Citations (Scopus) -
Systemic Ablation of Camkk2 Impairs Metastatic Colonization and Improves Insulin Sensitivity in TRAMP Mice: Evidence for Cancer Cell-Extrinsic CAMKK2 Functions in Prostate Cancer
Pulliam, T., Awad, D., Han, J., Murray, M., Ackroyd, J., Goli, P., Oakhill, J., Scott, J., Ittmann, M. & Frigo, D. E., 1 Jun 2022, In: Cells. 11, 12, 1890.Research output: Contribution to journal › Article › peer-review
Open Access10 Link opens in a new tab Citations (Scopus) -
Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes
Eduful, B. J., O'Byrne, S. N., Temme, L., Asquith, C. R. M., Liang, Y., Picado, A., Pilotte, J. R., Hossain, M. A., Wells, C. I., Zuercher, W. J., Catta-Preta, C. M. C., Zonzini Ramos, P., Santiago, A. D. S., Couñago, R. M., Langendorf, C. G., Nay, K., Oakhill, J. S., Pulliam, T. L., Lin, C. & Awad, D. & 4 others, , 12 Aug 2021, In: Journal of medicinal chemistry. 64, 15, p. 10849-10877 29 p.Research output: Contribution to journal › Article › peer-review
Open Access25 Link opens in a new tab Citations (Scopus)